CLSA Welcomes New Members, Visionary Award Honorees Recognized in Washington D.C. and Value of Innovation Update
President & CEO
CLSA – California Life Sciences Association
May 12, 2016
I would like to take a moment to welcome our newest CLSA members: Biotectix LLC, Brandwood Biomedical Pty Ltd, Gelzen, Inc., Grail, Inc., and Memphis Meats. These great organizations join our 750+ membership portfolio and add significantly to the expertise and resources available in the CLSA network.
Annual Spring DC Reception & Visionary Awardees: Reps. Tony Cardenas and Mimi Walters
On May 17, we’re excited to be hosting our Annual Spring Reception in Washington, D.C. Attendees will include Members of congress and staff from across the California delegation and beyond, along with CLSA members and friends.
This year, at the private Board of Directors and sponsors-only dinner immediately following the reception, we will be honoring a pair of bi-partisan legislators for their leadership advancing federal policies to promote life sciences research, investment and innovation.
In keeping with our thought leadership engagement, as part of our
second quarter CLSA Board Meeting activities prior to the awards ceremony, we’re thrilled that Dr. Francis Collins, Director of the National Institutes of Health (NIH), and Julie Goon, Senior Vice President, Public Affairs at Anthem, will be joining our Board for a discussion on the current healthcare landscape and innovation in life sciences.
CLSA Value of Innovation Initiative Update
We continue our work to highlight the value that innovative medicines bring to our economy and patient care, while calling attention to the tactics health insurance companies are using to shift costs to patients and restrict access.
In April, CLSA’s own Eve Bukowski, Vice President of State Government Relations, a cancer fighter, wife and mother of two, penned a letter to the editor of CALMatters, setting the record straight on a misleading article, “California Searches for Prescription to Treat Rising Drug Costs.” Click here to check out her letter.
In addition, as part of CLSA’s ongoing efforts to educate California and congressional legislators on the importance of implementing policies that protect biomedical innovation and access to care and rejecting policies that would hinder research, innovation and patient care, we recently released two new infographics.
“The Complicated Way We Pay for Medicines” focuses on the flow of medicines through the distribution pipeline, showing that the way we pay for medicines and get them to patients is far more complex than the simplistic soundbite characterization often heard. “Medical Innovation: Protecting Patient Access to Care” emphasizes the roles California’s innovators are playing in improving patient care and warns against policies that would short-circuit continued advancements. I invite you to learn more about our Value of Innovation initiative by checking out CLSA’s “Innovation Hub” at CALifeSciences.org/innovation.
CLSI Names Amgen Bay Area BioGENEius Winner
On April 15, our partner organization, the California Life Sciences Institute (CLSI), named Cupertino High School Sophomore Utkarsh Tandon the winner of the 2016 Amgen Bay Area BioGENEius Challenge, the premier competition for high school students that
recognizes outstanding research and innovation in the biotechnology field. As the California BioGENEius finalist, Tandon will head to the 2016 BIO International Convention to compete in the International BioGENEius Challenge. Winners will be announced during the Tuesday June 7 Plenary Session. Click here to learn more
CLSI Plans Release of 2016 Economic Impact of Bay Area Startups Report at BIO International Convention
California Life Sciences Institute (CLSI) will release a report on the economic impact of 137 pre-Series A life sciences startups at a program at the California Pavilion at the BIO International Convention on June 9, which will be followed by a panel of and reception with some of the Bay Area’s leading incubators and accelerators, including Bayer CoLaborator, Illumina Accelerator, JLABS, and QB3. The report looks at funds raised, patents filed, employee headcount, and percentage of women-led companies, demonstrating a strong impact on the local economy.
MobCon Digital Health Conference in Minneapolis
In April, I had the opportunity to attend the second annual MobCon Digital Health Conference in Minneapolis to join thought leaders around the U.S to discuss the advances in technology impacting health, wellness and business. This leading digital health conference featured presentations by the top minds in digital health, five educational tracks, exhibits, tech demos, unparalleled networking opportunities and more.
In efforts to foster new and sustained leadership in the converging digital health space, CLSA is a proud partner of MobCon’s upcoming Digital Health Program in San Francisco taking place Sept. 7. Click here to learn more.
President & CEO
California Life Sciences Association
PS – Have newsworthy items to submit for consideration for our monthly CLSA Bulletin? Feel free to send those tips to Bianca Leveriza, CLSA’s Associate, Marketing & Events (BLeveriza@CALifeSciences.org).